Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Standard of Care × 90 days × Clear all

Sponsor

Conditions

Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 10 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Hematologic Neoplasms 6 Hematopoietic and Lymphatic System Neoplasm 5 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Breast Carcinoma In Situ 4 Sarcoma 3 Motor Activity 3 Leukemia, Myeloid, Acute 3 Stomach Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Follicular 2 Lymphedema 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Frailty 2 Fallopian Tube Neoplasms 2 Carcinoma, Squamous Cell 2

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡